Search - tctmd.com

Displaying 681 - 700 of 1071

Sort: Relevancy | Date

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Industry News

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

September 17, 2015

News Daily News

UK TAVI Registry Supports Use of Subclavian Access When Transfemoral Not Possible

L.A. McKeown

September 16, 2015

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

September 15, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Conference News ESC 2015

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

L.A. McKeown

September 02, 2015

News Industry News

LEADLESS II Trial Results Published in The New England Journal of Medicine Confirm the Positive Benefits of the Nanostim Leadless Pacemaker

August 31, 2015

News Conference News ESC 2015

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

Caitlin E. Cox

August 31, 2015

News Daily News

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

August 25, 2015

News Daily News

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Caitlin E. Cox

August 24, 2015

News Daily News

Elective EVAR Yielding Better Short-Term Results at Lower Cost Than Before

Todd Neale

August 20, 2015

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

Advertisement

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke

UK TAVI Registry Supports Use of Subclavian Access When Transfemoral Not Possible

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

LEADLESS II Trial Results Published in The New England Journal of Medicine Confirm the Positive Benefits of the Nanostim Leadless Pacemaker

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Elective EVAR Yielding Better Short-Term Results at Lower Cost Than Before

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Novel Antisense Inhibitor Cuts High Triglyceride Levels

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

DES, BMS Both Suitable for Treating Patients With SVG Lesions

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content